The routine commissioning of ulipristal acetate 5mg tablets (Esmya®) is accepted in Devon for up to 4 courses of intermittent treatment of moderate to severe symptoms of uterine fibroids in adult women who have not reached menopause when uterine fibroid embolisation and/or surgical treatment options are not suitable or have failed.
Filename: | Ulipristal acetate 5mg tablets (Esmya®) for intermittent treatment of uterine fibroids |
Filetype: | |
Filesize: | 106.96 KB |
Date uploaded: | 11th November 2021 |
Date updated: | 8th December 2022 |